![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 6-(1h-indazol-6-yl)-n-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
2. Gs-9973
1. 1229208-44-9
2. Gs-9973
3. 6-(1h-indazol-6-yl)-n-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine
4. Entospletinib [inn]
5. Entospletinib (gs-9973)
6. Gs9973
7. 6i3o3w6o3b
8. Chembl3265032
9. Syk Inhibitor Gs-9973
10. 6-(1h-indazol-6-yl)-n-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine
11. Imidazo(1,2-a)pyrazin-8-amine, 6-(1h-indazol-6-yl)-n-(4-(4-morpholinyl)phenyl)-
12. 6-(1h-indazol-6-yl)-n-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine
13. 6-(1h-indazol-6-yl)-n-[4-(morpholin-4-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine
14. Entospletinib [usan:inn]
15. Unii-6i3o3w6o3b
16. 4puz
17. Imidazo[1,2-a]pyrazin-8-amine, 6-(1h-indazol-6-yl)-n-[4-(4-morpholinyl)phenyl]-
18. Gs 9973
19. Gs9973entospletinib
20. Gs-9973; Entospletinib
21. Entospletinib (usan/inn)
22. Entospletinib [usan]
23. Entospletinib [who-dd]
24. Gtpl7889
25. Schembl2483776
26. Dtxsid001317670
27. Hms3653d13
28. Hms3673e05
29. Hms3750e13
30. Amy14224
31. Bcp09582
32. Ex-a1120
33. Bdbm50015448
34. Mfcd28099806
35. Nsc781516
36. Nsc800988
37. S7523
38. Zinc98208742
39. Akos027295322
40. Ccg-264700
41. Db12121
42. Nsc-781516
43. Nsc-800988
44. Sb16830
45. Ncgc00378596-07
46. Ac-30236
47. As-17026
48. Da-36929
49. Hy-15968
50. Ft-0700130
51. Sw220048-1
52. D11209
53. A890877
54. J-690079
55. Q27077193
56. Entospletinib;6-(1h-indazol-6-yl)-n-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine
57. 6-cyclopropyl-8-fluoro-2-[2-(hydroxymethyl)-3-(1-methyl-5-{[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino}-6-oxo-1,6-dihydro-3-pyridi Nyl)phenyl]-1(2h)-isoquinolinone
Molecular Weight | 411.5 g/mol |
---|---|
Molecular Formula | C23H21N7O |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 411.18075832 g/mol |
Monoisotopic Mass | 411.18075832 g/mol |
Topological Polar Surface Area | 83.4 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 595 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of acute myeloid leukaemia